Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis

Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

51 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis trial results

Completed

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

NCT04818671

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator site 6 - US0010032 Carlsbad, California, United States
  • Investigator Site 47 - US0010021 Palo Alto, California, United States
  • Investigator Site 45 - US0010108 Boca Raton, Florida, United States
  • Investigator site 4 - US0010110 Port Charlotte, Florida, United States
View all 47 locations
View Trial Details
Completed

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT03971422

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0003 50081 Phoenix, Arizona, United States
  • Mg0003 50082 Scottsdale, Arizona, United States
  • Mg0003 50072 Los Angeles, California, United States
  • Mg0003 50092 Orange, California, United States
View all 112 locations
View Trial Details
Completed

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

NCT05681715

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0020 50092 Orange, California, United States
  • Mg0020 50099 San Francisco, California, United States
  • Mg0020 50561 Lexington, Kentucky, United States
  • Mg0020 50090 Winston-Salem, North Carolina, United States
View all 27 locations
View Trial Details
Completed

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

NCT05514873

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0017 50564 Scottsdale, Arizona, United States
  • Mg0017 50559 Los Angeles, California, United States
  • Mg0017 50593 Rancho Mirage, California, United States
  • Mg0017 50099 San Francisco, California, United States
View Trial Details
Completed

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

NCT04650854

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0007 50092 Orange, California, United States
  • Mg0007 50099 San Francisco, California, United States
  • Mg0007 50122 Miami, Florida, United States
  • Mg0007 50120 Miami, Florida, United States
View all 69 locations
View Trial Details
Completed

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

NCT03920293

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Irvine, California, United States
View all 106 locations
View Trial Details
Completed

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT04124965

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0004 50081 Phoenix, Arizona, United States
  • Mg0004 50072 Los Angeles, California, United States
  • Mg0004 50088 Washington D.C., District of Columbia, United States
  • Mg0004 50120 Miami, Florida, United States
View all 43 locations
View Trial Details
Completed

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

NCT03770403

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator Site 42 Carlsbad, California, United States
  • Investigator Site 8 Los Angeles, California, United States
  • Investigator Site 33 Orange, California, United States
  • Investigator Site 21 Palo Alto, California, United States
View all 52 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

NCT03772587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Momenta Investigational Site Phoenix, Arizona, United States
  • Momenta Investigational Site Tucson, Arizona, United States
  • Momenta Investigational Site Los Angeles, California, United States
  • Momenta Investigational Site Orange, California, United States
View all 61 locations
View Trial Details

Related conditions